Our Founder’s Story
My career was shaped by a promise I made as a child:
“I’m going to cure cancer.”
For as long as I can remember, I was acutely aware of the despair and uncertainty that a cancer diagnosis carried. I always felt a strong pull to help others overcome their fears and conquer this disease.
My passion for oncology only grew when my mother’s best friend was diagnosed with metastatic colon cancer, which happens to be the same disease she’d lost her father to. She and I searched tirelessly to find the best therapeutic interventions, to no avail. Treatment options for cancer patients were bleak. At this point, a career in cancer research called to me louder than ever. My greatest achievement would be to help deliver new, effective cures in the future.
From Vision to Purpose
Natasha Fallico, MSc
Driven by my goal to find new cures for cancer, I earned dual Bachelor’s degrees in Cellular and Molecular Biology and Neuroscience, followed by a Master of Science in Cellular and Molecular Oncology. In graduate school, I began contributing to the development of innovative immunotherapies, including CAR T cells, ADCs, and small-molecules, while ensuring rigorous compliance with ethical and regulatory standards.
I honed my scientific expertise over the course of 7 years through roles at Loyola University Medical Center, Abbott, and AbbVie, where I designed and executed experiments for oncology and immunology drugs, generated documents to support clinical trial approvals, led cross-functional teams, and presented findings to large scientific audiences. My work spans the full translational spectrum, from early discovery to clinical trial execution, providing me with a comprehensive understanding of tumor biology, immunology, drug development, and regulatory requirements.
In 2024, I founded OncoScript, a freelance medical writing practice, to bring my scientific and regulatory expertise to pharma and biotech companies, healthcare associations, and academic institutions. I specialize in creating compelling regulatory documents for oncology and immunology projects such as INDs, protocols, and investigator brochures, as well as manuscripts, literature reviews, posters, and educational materials for clinicians and researchers.
Whether translating complex science into clear, actionable documents or leading clinical teams to advance new therapies, my mission is consistent: to accelerate approvals, maximize scientific impact, and ultimately contribute to improved outcomes for patients.
Best,
